Skip to content 
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures, as well as non-pharmacological treatment of gastroesophageal reflux disease. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah. more
| Time Frame | MMSI | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -5.86% | -3.93% | -0.67% |
| 1-Month Return | -11.93% | -2.41% | -1.33% |
| 3-Month Return | -12.57% | 1.64% | -0.29% |
| 6-Month Return | -21.3% | 11.65% | 5.08% |
| 1-Year Return | -28.58% | 3.11% | 19.01% |
| 3-Year Return | 8.53% | 19.21% | 68.62% |
| 5-Year Return | 29.27% | 36.52% | 78.6% |
| 10-Year Return | 278.04% | 126.5% | 240.69% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 1.07B | 1.15B | 1.26B | 1.36B | 1.52B | [{"date":"2021-12-31","value":70.9,"profit":true},{"date":"2022-12-31","value":75.93,"profit":true},{"date":"2023-12-31","value":82.94,"profit":true},{"date":"2024-12-31","value":89.49,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Cost of Revenue | 589.42M | 631.88M | 673.49M | 713.18M | 777.64M | [{"date":"2021-12-31","value":75.8,"profit":true},{"date":"2022-12-31","value":81.26,"profit":true},{"date":"2023-12-31","value":86.61,"profit":true},{"date":"2024-12-31","value":91.71,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Profit | 485.33M | 519.10M | 583.87M | 643.33M | 738.27M | [{"date":"2021-12-31","value":65.74,"profit":true},{"date":"2022-12-31","value":70.31,"profit":true},{"date":"2023-12-31","value":79.09,"profit":true},{"date":"2024-12-31","value":87.14,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Margin | 45.16% | 45.10% | 46.44% | 47.43% | 48.70% | [{"date":"2021-12-31","value":92.72,"profit":true},{"date":"2022-12-31","value":92.61,"profit":true},{"date":"2023-12-31","value":95.35,"profit":true},{"date":"2024-12-31","value":97.38,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Operating Expenses | 424.42M | 431.54M | 458.73M | 487.64M | 553.55M | [{"date":"2021-12-31","value":76.67,"profit":true},{"date":"2022-12-31","value":77.96,"profit":true},{"date":"2023-12-31","value":82.87,"profit":true},{"date":"2024-12-31","value":88.09,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Operating Income | 60.92M | 87.56M | 123.94M | 155.69M | 184.72M | [{"date":"2021-12-31","value":32.98,"profit":true},{"date":"2022-12-31","value":47.4,"profit":true},{"date":"2023-12-31","value":67.1,"profit":true},{"date":"2024-12-31","value":84.29,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Total Non-Operating Income/Expense | (11.49M) | (10.83M) | (23.89M) | (10.69M) | (25.17M) | [{"date":"2021-12-31","value":-1149100000,"profit":false},{"date":"2022-12-31","value":-1083400000,"profit":false},{"date":"2023-12-31","value":-2389200000,"profit":false},{"date":"2024-12-31","value":-1068900000,"profit":false},{"date":"2025-12-31","value":-2517400000,"profit":false}] |
| Pre-Tax Income | 53.92M | 82.63M | 112.09M | 149.99M | 170.94M | [{"date":"2021-12-31","value":31.54,"profit":true},{"date":"2022-12-31","value":48.34,"profit":true},{"date":"2023-12-31","value":65.57,"profit":true},{"date":"2024-12-31","value":87.75,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Income Taxes | 5.46M | 8.11M | 17.68M | 29.64M | 42.45M | [{"date":"2021-12-31","value":12.87,"profit":true},{"date":"2022-12-31","value":19.11,"profit":true},{"date":"2023-12-31","value":41.65,"profit":true},{"date":"2024-12-31","value":69.82,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Income After Taxes | 48.45M | 74.52M | 94.41M | 120.36M | 128.49M | [{"date":"2021-12-31","value":37.71,"profit":true},{"date":"2022-12-31","value":57.99,"profit":true},{"date":"2023-12-31","value":73.48,"profit":true},{"date":"2024-12-31","value":93.67,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Income From Continuous Operations | 48.45M | 74.52M | 100.18M | 120.36M | 128.49M | [{"date":"2021-12-31","value":37.71,"profit":true},{"date":"2022-12-31","value":57.99,"profit":true},{"date":"2023-12-31","value":77.97,"profit":true},{"date":"2024-12-31","value":93.67,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | 48.45M | 74.52M | 94.41M | 120.36M | 128.49M | [{"date":"2021-12-31","value":37.71,"profit":true},{"date":"2022-12-31","value":57.99,"profit":true},{"date":"2023-12-31","value":73.48,"profit":true},{"date":"2024-12-31","value":93.67,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| EPS (Diluted) | 2.37 | 2.69 | 3.01 | 3.48 | 3.83 | [{"date":"2021-12-31","value":61.88,"profit":true},{"date":"2022-12-31","value":70.23,"profit":true},{"date":"2023-12-31","value":78.59,"profit":true},{"date":"2024-12-31","value":90.86,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| MMSI | |
|---|---|
| Cash Ratio | 1.87 |
| Current Ratio | 4.34 |
| Quick Ratio | 2.95 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| MMSI | |
|---|---|
| ROA (LTM) | 4.75% |
| ROE (LTM) | 8.67% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| MMSI | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.41 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.59 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| MMSI | |
|---|---|
| Trailing PE | 34.83 |
| Forward PE | 18.28 |
| P/S (TTM) | 2.88 |
| P/B | 2.78 |
| Price/FCF | 57 |
| EV/R | 3.15 |
| EV/Ebitda | 14.40 |
| PEG | 1.54 |
Merit Medical Systems Inc (MMSI) share price today is $72.66
Yes, Indians can buy shares of Merit Medical Systems Inc (MMSI) on Vested. To buy
Yes, you can purchase fractional shares of Merit Medical Systems Inc (MMSI) via the Vested app. You can start investing in Merit Medical Systems Inc (MMSI) with a minimum investment of $1.
You can invest in shares of Merit Medical Systems Inc (MMSI) via Vested in three simple steps:
The 52-week high price of Merit Medical Systems Inc (MMSI) is $107.27. The 52-week low price of Merit Medical Systems Inc (MMSI) is $72.61.
The price-to-earnings (P/E) ratio of Merit Medical Systems Inc (MMSI) is 34.8294
The price-to-book (P/B) ratio of Merit Medical Systems Inc (MMSI) is 2.78
The dividend yield of Merit Medical Systems Inc (MMSI) is 0.00%
The market capitalization of Merit Medical Systems Inc (MMSI) is $4.37B
The stock symbol (or ticker) of Merit Medical Systems Inc is MMSI
Consider the share price of Merit Medical Systems Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Merit Medical Systems Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Merit Medical Systems Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Merit Medical Systems Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Merit Medical Systems Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Merit Medical Systems Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
